Growth at Reasonable Price
Results
5
1 new
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NWRN | CHF 11.70 | 1.0% | 67.4% | CHF 243.4m | CHF 47.48 | 13.7 | 50.2% | n/a | Pharmaceuticals & Biotech | ||
LMN | CHF 13.25 | 2.3% | -16.7% | CHF 140.6m | CHF 19.16 | 13.0 | 20.5% | 2.9% | Consumer Services | ||
NOVN New | CHF 125.54 | 2.5% | 36.2% | CHF 229.8b | CHF 123.68 | 22.2 | 11.5% | 2.9% | Pharmaceuticals & Biotech | ||
RIEN | CHF 2.89 | -6.0% | -95.7% | CHF 392.9m | CHF 3.40 | 0.4 | 113.1% | 0% | Capital Goods | ||
CICN | CHF 118.80 | 5.5% | -35.6% | CHF 522.7m | CHF 169.90 | 30.9 | 32.2% | 0% | Tech |
Page 1 of 1